Carregant...

PRIORITIZING FUTURE RESEACH ON OFF-LABEL PRESCRIBING: RESULTS OF A QUANTITATIVE EVALUATION

BACKGROUND: Drug use for indications not approved by the Food and Drug Administration exceeds 20% of prescribing. Available compendia indicate that a minority of off-label uses are well supported by evidence. Policy makers, however, lack information to identify where systematic reviews of the eviden...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Pharmacotherapy
Autors principals: Walton, Surrey M., Schumock, Glen T., Lee, Ky-Van, Alexander, G. Caleb, Meltzer, David, Stafford, Randall S.
Format: Artigo
Idioma:Inglês
Publicat: 2008
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4406412/
https://ncbi.nlm.nih.gov/pubmed/19025425
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1592/phco.28.12.1443
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!